
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Translating IL-6 biology into effective treatments
Ernest Choy, Fabrizio De Benedetti, Tsutomu Takeuchi, et al.
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 6, pp. 335-345
Open Access | Times Cited: 543
Ernest Choy, Fabrizio De Benedetti, Tsutomu Takeuchi, et al.
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 6, pp. 335-345
Open Access | Times Cited: 543
Showing 1-25 of 543 citing articles:
Harnessing cytokines and chemokines for cancer therapy
David Propper, Frances R. Balkwill
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 4, pp. 237-253
Closed Access | Times Cited: 617
David Propper, Frances R. Balkwill
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 4, pp. 237-253
Closed Access | Times Cited: 617
Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption
Hideki Kitaura, Aseel Marahleh, Fumitoshi Ohori, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5169-5169
Open Access | Times Cited: 261
Hideki Kitaura, Aseel Marahleh, Fumitoshi Ohori, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5169-5169
Open Access | Times Cited: 261
Targeting IL-6 trans-signalling: past, present and future prospects
Stefan Rose‐John, Brendan J. Jenkins, Christoph Garbers, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 666-681
Open Access | Times Cited: 257
Stefan Rose‐John, Brendan J. Jenkins, Christoph Garbers, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 666-681
Open Access | Times Cited: 257
Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines
Lang Rao, Shuai Xia, Wei Xu, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 44, pp. 27141-27147
Open Access | Times Cited: 213
Lang Rao, Shuai Xia, Wei Xu, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 44, pp. 27141-27147
Open Access | Times Cited: 213
Exploring treatment options in cancer: Tumor treatment strategies
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 186
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 186
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
Felice Rivellese, Anna E. A. Surace, Katriona Goldmann, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1256-1268
Open Access | Times Cited: 185
Felice Rivellese, Anna E. A. Surace, Katriona Goldmann, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1256-1268
Open Access | Times Cited: 185
Juvenile idiopathic arthritis
Alberto Martini, Daniel J. Lovell, Salvatore Albani, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 180
Alberto Martini, Daniel J. Lovell, Salvatore Albani, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 180
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
Mansur Aliyu, Fatema Tuz Zohora, Abubakar Umar Anka, et al.
International Immunopharmacology (2022) Vol. 111, pp. 109130-109130
Open Access | Times Cited: 163
Mansur Aliyu, Fatema Tuz Zohora, Abubakar Umar Anka, et al.
International Immunopharmacology (2022) Vol. 111, pp. 109130-109130
Open Access | Times Cited: 163
Fibroblast pathology in inflammatory diseases
Kevin Wei, Hung Nguyen, Michael B. Brenner
Journal of Clinical Investigation (2021) Vol. 131, Iss. 20
Open Access | Times Cited: 161
Kevin Wei, Hung Nguyen, Michael B. Brenner
Journal of Clinical Investigation (2021) Vol. 131, Iss. 20
Open Access | Times Cited: 161
Role of IL-6 in the regulation of neuronal development, survival and function
Kai K. Kummer, Maximilian Zeidler, Theodora Kalpachidou, et al.
Cytokine (2021) Vol. 144, pp. 155582-155582
Open Access | Times Cited: 139
Kai K. Kummer, Maximilian Zeidler, Theodora Kalpachidou, et al.
Cytokine (2021) Vol. 144, pp. 155582-155582
Open Access | Times Cited: 139
Targeted Immunotherapy for Autoimmune Disease
Seung Min Jung, Wan‐Uk Kim
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 110
Seung Min Jung, Wan‐Uk Kim
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 110
Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context
Federico Angriman, Bruno L. Ferreyro, Lisa Burry, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 6, pp. 655-664
Open Access | Times Cited: 105
Federico Angriman, Bruno L. Ferreyro, Lisa Burry, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 6, pp. 655-664
Open Access | Times Cited: 105
Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
Yi Wang, Kai Conrad Cecil Johnson, Margaret E. Gatti‐Mays, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 93
Yi Wang, Kai Conrad Cecil Johnson, Margaret E. Gatti‐Mays, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 93
Oral drug delivery platforms for biomedical applications
Jiang Ouyang, Zhongyang Zhang, Bo Deng, et al.
Materials Today (2023) Vol. 62, pp. 296-326
Closed Access | Times Cited: 83
Jiang Ouyang, Zhongyang Zhang, Bo Deng, et al.
Materials Today (2023) Vol. 62, pp. 296-326
Closed Access | Times Cited: 83
Interleukin 6: at the interface of human health and disease
Elena Grebenciucova, Stephen VanHaerents
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 79
Elena Grebenciucova, Stephen VanHaerents
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 79
IL-6: The Link Between Inflammation, Immunity and Breast Cancer
Juan Chen, Yanghui Wei, Weiqin Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 76
Juan Chen, Yanghui Wei, Weiqin Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 76
Blood protein assessment of leading incident diseases and mortality in the UK Biobank
Danni A. Gadd, Robert F. Hillary, Zhana Kuncheva, et al.
Nature Aging (2024) Vol. 4, Iss. 7, pp. 939-948
Open Access | Times Cited: 34
Danni A. Gadd, Robert F. Hillary, Zhana Kuncheva, et al.
Nature Aging (2024) Vol. 4, Iss. 7, pp. 939-948
Open Access | Times Cited: 34
Rheumatoid arthritis: pathogenesis and therapeutic advances
Ying Gao, Yunkai Zhang, Xingguang Liu
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 31
Ying Gao, Yunkai Zhang, Xingguang Liu
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 31
Recent advances and evolving concepts in Still’s disease
Piero Ruscitti, Luca Cantarini, Peter A. Nigrović, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 116-132
Closed Access | Times Cited: 30
Piero Ruscitti, Luca Cantarini, Peter A. Nigrović, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 116-132
Closed Access | Times Cited: 30
Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis
Feiyang Ma, Pei‐Suen Tsou, Mehrnaz Gharaee‐Kermani, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22
Feiyang Ma, Pei‐Suen Tsou, Mehrnaz Gharaee‐Kermani, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22
The ouroboros of autoimmunity
Jean‐Laurent Casanova, Jessica N. Peel, Jean Donadieu, et al.
Nature Immunology (2024) Vol. 25, Iss. 5, pp. 743-754
Closed Access | Times Cited: 22
Jean‐Laurent Casanova, Jessica N. Peel, Jean Donadieu, et al.
Nature Immunology (2024) Vol. 25, Iss. 5, pp. 743-754
Closed Access | Times Cited: 22
Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies
Farzana Yasmeen, Rameez Hassan Pirzada, Bilal Ahmad, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7666-7666
Open Access | Times Cited: 21
Farzana Yasmeen, Rameez Hassan Pirzada, Bilal Ahmad, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7666-7666
Open Access | Times Cited: 21
Lupus Nephritis Biomarkers: A Critical Review
Fatima K. Alduraibi, George C. Tsokos
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 805-805
Open Access | Times Cited: 20
Fatima K. Alduraibi, George C. Tsokos
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 805-805
Open Access | Times Cited: 20
Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs
Akey Krishna Swaroop, Preeya Negi, Ayushi Kar, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 76, pp. 48-76
Closed Access | Times Cited: 17
Akey Krishna Swaroop, Preeya Negi, Ayushi Kar, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 76, pp. 48-76
Closed Access | Times Cited: 17
Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment
Yue Deng, Qingyan Chen, Xiao Yang, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 1224-1240
Open Access | Times Cited: 17
Yue Deng, Qingyan Chen, Xiao Yang, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 1224-1240
Open Access | Times Cited: 17